Atlas Trials

Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis

Clinical trial NCT01909778 · COMPLETED

Trial details

NCT number
NCT01909778
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis CLiver Cirrhosis
Start date
2008-06-01
Primary completion
2008-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.